Bio-Techne Corp

NASDAQ: TECH
$66.73
-$2.08 (-3.0%)
Closing price April 12, 2024
Bio-Techne Corp is a leading developer and manufacturer of life science reagents, instruments, and services. With a focus on research and clinical diagnostics, it offers a wide range of products including cytokines, growth factors, antibodies, and diagnostic assays. The company caters to the global market, providing tools for protein analysis, genetic screening, and oncology diagnostics. Bio-Techne, known for its innovation in cell and gene therapy, plays a crucial role in advancing scientific research and healthcare diagnostics.

Before the Bell: American Airlines Sours, Warner Bros Drops HBO Name From Max, the Most Squeezable Shorts
Thursday's premarket session was slightly positive, and it would take something major to push the markets in one direction or the other.
Paul Ausick
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Apple, Best Buy, Disney, Emerson Electric, Micron Technology, Tapestry and More
Tuesday's top analyst upgrades and downgrades included Accenture, Analog Devices, Apple, Baxter International, Best Buy, Coterra Energy, Emerson Electric, Johnson Controls, Lam Research, Micron...
Lee Jackson
Published:

Top Analyst Upgrades and Downgrades: Delta, Hasbro, Illumina, Lululemon, Micron, Nike, Penn National, Shopify, Southwest, Starbucks, Zynga and More
Wednesday's top analyst upgrades and downgrades included Delta Air Lines, Hasbro, Illumina, Lululemon Athletica, Micron Technologies, Nike, Penn National, Shopify, Southwest Airlines, Starbucks and...
Jon C. Ogg
Published:

Top Analyst Upgrades and Downgrades: AMC, Apple, Cerence, Chipotle, Ciena, Disney, Dollar Tree, Freshpet, LATAM, Nio, Peloton, Ping, Tesla and More
Wednesday's top analyst upgrades and downgrades included AMC Entertainment, Apple, Cerence, Chipotle Mexican Grill, Ciena, Dollar Tree, Freshpet, LATAM Airlines, Nio, Peloton Interactive, Ping, Tesla...
Jon C. Ogg
Published:

Winning Ideas in Biotech/Pharma After JPMorgan Healthcare Conference
For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past week.
Chris Lange
Published:

Top Analyst Upgrades and Downgrades: Cars.com, Comerica, Cummins, Enbridge, Lyft, Micron, Roku, Stryker, Uber, Visa, Western Digital and More
The top analyst upgrades, downgrades and initiations on Tuesday included Cars.com, Comerica, Cummins, Enbridge, Lyft, Micron Technology, Roku, Stryker, Uber Technologies, Visa and Western Digital.
Jon C. Ogg
Published:

Top Analyst Upgrades and Downgrades: Alector, Bed Bath & Beyond, Dillard's, Foot Locker, Hasbro, Kraft Heinz, Vale, Xilinx, Zoetis and More
The top analyst upgrades, downgrades and initiations seen on Monday included Alector, Bed Bath & Beyond, Dillard's, Foot Locker, Hasbro, Kraft Heinz, Vale, Xilinx and Zoetis.
Jon C. Ogg
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: Boston Scientific, Etsy, GE, Morgan Stanley, SeaWorld, Skechers, Shopify, Square, Tesla and More
The top analyst upgrades, downgrades and initiations seen on Tuesday included Boston Scientific, Etsy, General Electric, Morgan Stanley, SeaWorld, Skechers, Shopify, Square and Tesla.
Jon C. Ogg
Published:
Last Updated:

Why the National Institute of Health New Budget Looks So Promising
According to a recent analyst report by Janney, the National Institute of Health budget that was approved last Friday could be a big boost for some select biopharma stocks.
Chris Lange
Published:
Last Updated:

Why One Analyst Is Growing Very Bullish on Life Sciences
Over the past five, 10 and 20 years, the life science and bioproduction segments have tended to outperform the S&P 500 more often than not.
Chris Lange
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: Baker Hughes, Cree, Freeport-McMoRan, GrubHub, Silver Wheaton, Dynegy, Panera, Ulta and More
The top analyst upgrades, downgrades and initiations seen on Thursday include Baker Hughes, Cree, Freeport-McMoRan, GrubHub, Silver Wheaton, Dynegy, Panera Bread and Ulta Beauty.
Jon C. Ogg
Published:
Last Updated:

Top Analyst Downgrades and Stocks to Sell: Dean Foods, Dendreon, Mylan and More
Source: Jon OggInvestors frequently see analyst upgrades and Buy ratings from Wall Street research calls, but they often do not get to see the so-called Sell ratings. 24/7 Wall St. reviews many fresh...
Jon C. Ogg
Published:
Last Updated:

Biotech Business Daily (BTRX, BMRN, DSCO, ENDP, MNKD, MIPI, QSC, TECH)
Today almost feels like the "March of Biotech-inguins" because most of the movers were small companies you might otherwise miss.  Here were the big movers: Barrier Therapeutics...
Douglas A. McIntyre
Published: